PIERIS PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q4 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Pieris Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2013 to Q3 2024.
  • Pieris Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 13, 2024 was 1.32M shares, a 98.7% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.32M -97.5M -98.7% Nov 13, 2024 10-Q 2024-11-13
Q2 2024 1.32M -97.5M -98.7% Aug 8, 2024 10-Q 2024-08-14
Q1 2024 98.9M +24.4M +32.8% Apr 17, 2024 10-K/A 2024-04-29
Q3 2023 98.9M +24.4M +32.9% Nov 9, 2023 10-Q 2023-11-14
Q2 2023 98.9M +24.4M +32.9% Aug 7, 2023 10-Q 2023-08-10
Q1 2023 74.5M +442K +0.6% Mar 28, 2023 10-K 2023-03-31
Q3 2022 74.4M +2.34M +3.25% Nov 1, 2022 10-Q 2022-11-04
Q2 2022 74.4M +7.7M +11.5% Aug 1, 2022 10-Q 2022-08-04
Q1 2022 74.1M +14.4M +24% Feb 24, 2022 10-K/A 2022-07-06
Q3 2021 72.1M +16.1M +28.8% Oct 29, 2021 10-Q 2021-11-02
Q2 2021 66.7M +14.3M +27.3% Aug 2, 2021 10-Q 2021-08-05
Q1 2021 59.7M +4.51M +8.16% Mar 29, 2021 10-K 2021-03-31
Q3 2020 56M +995K +1.81% Oct 30, 2020 10-Q 2020-11-04
Q2 2020 52.4M +3.01M +6.09% Aug 3, 2020 10-Q 2020-08-10
Q1 2020 55.2M +6.06M +12.3% Mar 9, 2020 10-K 2020-03-13
Q3 2019 55M +826K +1.53% Nov 7, 2019 10-Q 2019-11-12
Q2 2019 49.4M -4.64M -8.59% Aug 5, 2019 10-Q 2019-08-09
Q1 2019 49.2M -4.7M -8.74% Mar 11, 2019 10-K 2019-03-18
Q3 2018 54.1M +9.36M +20.9% Nov 5, 2018 10-Q 2018-11-07
Q2 2018 54M +9.73M +22% Aug 8, 2018 10-Q 2018-08-09
Q1 2018 53.9M +10.8M +25.1% Mar 12, 2018 10-K 2018-03-15
Q3 2017 44.8M +1.74M +4.03% Nov 7, 2017 10-Q 2017-11-13
Q2 2017 44.3M +1.25M +2.9% Aug 8, 2017 10-Q 2017-08-11
Q1 2017 43.1M +3.23M +8.1% Mar 20, 2017 10-K 2017-03-30
Q3 2016 43.1M +3.3M +8.3% Nov 7, 2016 10-Q 2016-11-10
Q2 2016 43.1M +3.33M +8.37% Aug 7, 2016 10-Q 2016-08-11
Q1 2016 39.8M +10.4M +35.4% Mar 20, 2016 10-K 2016-03-23
Q3 2015 39.8M +33.5M +536% Nov 9, 2015 10-Q 2015-11-13
Q2 2015 39.7M +33.6M +551% Aug 13, 2015 10-Q 2015-08-13
Q1 2015 29.4M +24.4M +489% Mar 27, 2015 10-K 2015-03-30
Q3 2014 6.25M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 6.1M Jun 30, 2014 10-K 2014-09-12
Q1 2014 5M Mar 31, 2014 10-Q 2014-06-02
Q4 2013 5M Dec 31, 2013 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.